October 31, 2014 News by Patricia Inacio, PhD Neuroprotective Qualities of Masitinib Drug in Stroke Encouraging For MS Indication An encouraging experimental drug that is being developed for Multiple Sclerosis continues to show promise in being able to offer neuroprotective benefits — an effect that could slow and eventually cure MS.Ā Masitinib,Ā which is being developed by AB Science forĀ numerous neurological indications, including Alzheimer’s disease, progressive multiple sclerosis, and amyotrophic…
October 30, 2014 News by Isaura Santos Multiple Sclerosis, Autoimmune Disease Diagnoses, Treatments To Improve Using New DNA Software Researchers from UC San Francisco, the Broad Institute of MIT and Harvard, and Yale School of Medicine recently developed a software tool that helps researchers understand the complex genetic origins of many autoimmune diseases and, ultimately, to better diagnose and treat them. The study was published yesterday inĀ …
October 29, 2014 News by Patricia Silva, PhD Sydney Bikers Join Efforts to Fundraising on MS Gong Ride Sunday Next Sunday, November 2nd,Ā Sydney, Australia will hold one of the country’s largest fundraising events to support multiple sclerosis research and advocacy, theĀ MS Gong Ride, aĀ one day community bike ride designed to collect $3.8 million. Each biker is asked to help raise $250 for the historic ride that celebrates its…
October 29, 2014 News by Patricia Inacio, PhD Experimental Multiple Sclerosis Drug Clears Key FDA Hurdle, To Be Tested in U.S. A new human clinical trial testing the drug ATL1102 to treat Multiple Sclerosis was approved by FDA, carrying the promise of new therapeutics to affected patients. Antisense Therapeutics Limited (ANP) announced recently in a press release the FDA’s positive decision to approve their request to submit an Investigational…
October 28, 2014 News by Patricia Silva, PhD Philip De Jager Awarded 2014 Barancik Prize for Innovation in MS Research The National Multiple Sclerosis Society granted the 2014Ā Barancik Prize for Innovation in MS Research to Philip Laurence De Jager, MD, PhD, who is a neurologist atĀ Brigham and Women’s Hospital, as well as an associate professor of neurology at the Harvard Medical School. The award, meant to…
October 27, 2014 News by Patricia Silva, PhD Positive Data from Two Key MS Trials Added To Aubagio’s U.S. Label The Food and Drug Administration (FDA) recently accepted the results from Genzyme’s TOWER and TOPIC Ā clinical trials,Ā which assessed the safety and efficacy of oral, once-daily AubagioĀ® (teriflunomide) for Multiple Sclerosis, and will add the positive data to the productās U.S. label. Genzyme is a leader in the development…
October 27, 2014 News by Patricia Inacio, PhD IGF-1 Could Suppress Immune System in Multiple Sclerosis, Other Autoimmune Disease Among autoimmune diseases, Multiple Sclerosis is one of the most progressive and debilitating, affecting between 300,000 and 400,000 people in the United States alone. The cause of the disease remains elusive to researchers, making it extremely difficult to research and develop effective therapies for treating symptoms and reversing neural…
October 24, 2014 News by Patricia Silva, PhD MS Society Canada Urges Parliamentarians to Improve MS Clinics While Canada is home to one of the world’s most comprehensive social healthcare systems, it is unfortunately home to one of the largestĀ multiple sclerosisĀ patient populations as well. According to the Multiple Sclerosis Society of Canada, at least 100,000 Canadians have the disease, and at least 20,000 of them live…
October 24, 2014 News by Patricia Silva, PhD Opexa Joins National Multiple Sclerosis Society to Sponsor Walk MS The National Multiple Sclerosis Society‘sĀ Lone Star Chapter, which is sponsoring theĀ nonprofit organizationās annualĀ Houston-area Walk MSĀ fundraisers, has announced that Woodlands-based biopharmaceutical companyĀ Opexa Therapeutics, a company currently developing personalized immunotherapies for multiple sclerosis (MS), will also support the fundraising effort. This is the fourth consecutive…
October 23, 2014 News by Patricia Inacio, PhD Study Finds No Link Between Vaccines and Multiple Sclerosis A new study entitled, āVaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseasesā published in theĀ JAMA Neurology journal, reports that no association was observed between vaccinations and an increased risk for Multiple Sclerosis or other central nervous system…
October 23, 2014 News by Patricia Silva, PhD Consortium of MS Centers Hosts Annual Meeting Next May in Indiana The Consortium of Multiple Sclerosis Centers (CMSC) has announced that its next annual meeting will be held in 2015 between May 27 th and 30th at the JW Marriott Hotel in Indianapolis, Indiana. TheĀ 2015 Annual Meeting of the Consortium of Multiple Sclerosis Centers aims to gather healthcare professionals as…
October 22, 2014 News by Patricia Inacio, PhD High Level of Multiple Sclerosis Diagnoses Observed Among Patients with Inflammatory Eye Disease The first and largest study on the association between Multiple Sclerosis (MS) and Uveitis was recently presented at the 18th annual meeting of the American Academy of Ophthalmology.Ā The meeting was held at the McCormick Place in Chicago between October 17-21, 2014. Uveitis is a disorder characterized by inflammation of…
October 22, 2014 News by Patricia Silva, PhD Dimension Data Helps Raise $130K for National MS Society One of the most effective and engaging fundraising strategies the National Multiple Sclerosis Society organizes annually is the Bike MS series. Several times a year, in different locations throughout the country, thousands of MS patients from all over the world, as well as friends, family, and advocacy…
October 21, 2014 News by Patricia Inacio, PhD Multiple Sclerosis Patients May Benefit From Use of Dorsiflexion Assist Orthotic, According To Research Much of the research and development focus for treating Multiple Sclerosis revolves around pharmaceuticals. However, the development and use of novel medical devices are also becoming a factor in treating the disease as well. A new study entitled āA dorsiflexion assist orthosis reduces the physiological cost…
October 21, 2014 News by Patricia Silva, PhD David Osmond Sings for Novartis MS Awareness Campaign A member of the musical Osmond family, David Osmond, recently released a music video for his inspirational song “I Can Do This.” He has dedicated it to men and women all over the world who are faced with challenges that make them doubt their abilities and self-worth, but the real…
October 20, 2014 News by Patricia Silva, PhD MS Blueprint Online Program by Biogen Helps Patients Live Happier Cambridge, Massachusetts-basedĀ Biogen IdecĀ has just announced a new support program for people living with multiple sclerosis (MS) that encourages patients to turn their attention to daily activities that enhance their emotional and mental state. The newly launched MS Blueprint program assists patients and caregivers in setting positive and realistic goals,…
October 20, 2014 News by Patricia Silva, PhD 5-Course Dinner Raises $445K for Multiple Sclerosis Society of Canada Heartwarming support for multiple sclerosis campaigns and charity events poured in at last week’s exclusive gastronomic fundraising event, theĀ ToquĆ©! for MSĀ benefit, made possible by the tireless, collaborative efforts of Louis Vachon, the event’s Honorary Chair and President and CEO of the National Bank, andĀ ToquĆ©! Restaurant’s Grand Chef Relais & ChĆ¢teaux,…
October 17, 2014 News by Isaura Santos “MS Radio” Offers Multiple Sclerosis Patients Breaking News, Articles & Tips About the Disease Multiple Sclerosis information resourceĀ MSology.com has announced the launch ofĀ MS Radio, an exclusive MS-focused radio program, to celebrate the organization’s second anniversary. MSology.com provides news, feature articles and practical tips to more than 100,000 people worldwide. The first radio episode (available here) is a…
October 17, 2014 News by Patricia Silva, PhD Free Continuing Education for MS Care Providers Starts in November Several national health organizations have come together to design a series of continuing education opportunities focused on better managing multiple sclerosis entitled,Ā Optimizing Multiple Sclerosis Management.Ā Thanks to the collaborative efforts of leading MS organization for professionals, the Consortium of Multiple Sclerosis Centers (CMSC); Nurse Practitioner Alternatives (NPA), and Spire Learning, allied…
October 16, 2014 News by Patricia Silva, PhD U.S. Supreme Court Gives Teva Mixed Reception on Copaxone Patent Case The U.S. Supreme Court deliberated on a request from Teva Pharmaceutical Industries Ltd. to preserve the patent of its multiple sclerosis drug Copaxone from generic competitors until September 2015. Recent reports indicate that the court gave the company a mixed opinion. The hearing occurred this…
October 16, 2014 News by Patricia Silva, PhD Revenge Star Madeleine Stowe is the New Face of Multiple Sclerosis Featureflash / Shutterstock.com Television’s “Queen of Mean,” Revenge‘s Madeleine Stowe,Ā recently opened up about her early memories of her father living with multiple sclerosis (MS), a progressive neurodegenerative disease that, until today, does not have a known cure. However, thanks to the efforts of countless researchers and MS…
October 15, 2014 News by BioNews Staff Spasticity Drug to be Tested on Multiple Sclerosis Patients in Early 2015 Concert Pharmaceuticals, Inc. will announce their latest results from the Phase 1 data of CTP-354, a drug developed to treat spasticity ā a chronic condition associated with patients with brain disorders, including Multiple Sclerosis —Ā at the next American Neurological Associationās Annual Meeting in Baltimore, Maryland. The Phase 1 randomized,…
October 15, 2014 News by Patricia Silva, PhD Urinary Prosthesis Better than Catheterization for Female MS Patients One of the concerns patients with neurologic diseases such as multiple sclerosisĀ face is decline or loss of bladder control. It can be an embarrassing and frustrating problem, which is estimated to occur in about 80% of MS patients, as the disease causes a slowing down or interruption in signal transmission…
October 14, 2014 News by Isaura Santos Multiple Sclerosis Patients Gain Access To Novel Image Sharing Platform StatRad is a technology leader in radiology and HealthCare Journey a virtual multiple sclerosis center and educator website guided by the motto,Ā Stop Searching Start Learning. According to a recentĀ press release, the two companies have teamed up to offer…
October 14, 2014 News by Patricia Silva, PhD New Multiple Sclerosis Research Will Focus On Cytokine Regulation, Neuroprotection, Tolerance Induction Evotec AG,Ā a German company specializing in the provision of drug discovery resources to biotech companies and learning institutions, announced that is going to begin three new research projects for the treatment of multiple sclerosis (MS), which will be supported by funds from theĀ German Federal Ministry of Education…
October 14, 2014 News by Patricia Silva, PhD Ankar Pharma Opens Crowdfunding for Promising MS Drug Spanish-Filipino biopharmaceutical startupĀ Ankar PharmaĀ is working on a promising treatment for multiple sclerosis (MS). Dr. Ana Martinez, a professor and researcher at theĀ Biological Research Center (CIB) of the Spanish National Council for Research (CSIC), explains that while there are several palliative treatments available on the market…
October 13, 2014 News by Patricia Silva, PhD PHARMAC Approves Funding New RRMS Treatments in New Zealand New Zealand-basedĀ Pharmaceutical Management Agency (PHARMAC) has approved the funding of new treatments for multiple sclerosis (MS), which are expected not only to reach more patients, but also be more effective in curtailing the disease’s progressive symptoms. The therapies currently funded are meant for the treatment ofĀ …
October 13, 2014 News by Patricia Silva, PhD Alabama Representative Honored at National MS Society Ball The National Multiple Sclerosis SocietyĀ recently honored several admirable MS advocates and leaders during the annual NMSS Ambassadors Ball, held in Washington, D.C., to benefit local MS patients and research initiatives. The upscale black-tie evening brought together some of the most accomplished industry leaders and celebrities at the Georgetown Ritz…
October 10, 2014 News by Patricia Silva, PhD MS Association in Germany Invites Thomas Erning to Present Novel Germany’s Multiple Sclerosis Association is hosting an event dedicated to recognizing those who have devoted much of their time and effort to supporting and empowering MS patients in spite of their debilitating condition. The Chairman, former president Christian Wulff, will be present on Thursday, October 16, in Berlin to…
October 10, 2014 News by Patricia Inacio, PhD Why NAD+ Could Become a New Multiple Sclerosis Therapy A new study entitled āNAD+ protects against EAE by regulating CD4+ T-cell differentiationā published in October issue of Nature Communications reports that NAD+ can be a future therapeutic drug to treat Multiple Sclerosis. Multiple sclerosis (MS) is a type of autoimmune disease where the inner…